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Abstract
Background: Global cerebral blood ﬂow (CBF), as a measure of cerebral perfusion, can be non-
invasively studied using Doppler sonography. Chronic heart failure (CHF) increases the risk of
stroke and dementia. One of the possible causes may be cerebral hypoperfusion in CHF patients.
Therefore, we aimed to investigate the relationship between CBF and CHF severity.
Methods: The study was performed in 76 ischemic or idiopathic dilatative cardiomyopathy
patients, left ventricular ejection fraction (LVEF) < 40%, with no clinical evidence of decompen-
sation and 20 healthy volunteers. Each CHF patient was categorized according to the New NYHA
criteria. All patients underwent Doppler echocardiography examination (GE Vivid 7). The LVEF
was quantiﬁed using the Simpson method. CBF was estimated by a 7.0-MHz linear transducer
of a computed sonography system (Toshiba Power vision 6000). CBF volume was determined as
the sum of the ﬂow volumes of the ICA and the VA of both sides.
Results: Atrial ﬁbrillation was noted in 30%, left bundle branch block in 26%, while pacemaker
was implanted in 9% of patients with CHF. History of myocardial infarction was presented in
64% of patients. No differences in age, waist/hip ratio, body mass index and lipid proﬁle were
found between CHF patients and healthy subjects. CBF was calculated in 71 of 76 patients.
Three patients had occlusion of ICA, while VA was occluded in another two patients. Others did
not have a hemodynamically signiﬁcant ICA and VA stenosis. CBF volume was decreased in CHF
patients, (677± 170) according to control (783± 128).
Conclusion: Our results of noninvasive sonographic measurement of CBF according to LVEF and
NYHA criteria, suggest on signiﬁcantly reduced CBF in CHF patients.
 acces© 2012 Elsevier GmbH.Open∗ Corresponding author. Tel.: +381 112477164; fax: +381 113609458.
E-mail address: lepict@gmail.com (T. Lepic).
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Introduction
Brain dysfunction associated with structural brain changes,
are the important but under-recognised complication of
chronic heart failure (CHF) [1—3]. In addition, CHF increases
the risk of dementia and Alzheimer disease in later life
[4]. One of the possible causes may be cerebral hypo-
perfusion secondary to low cardiac output in patients with
CHF apart from biohumoral, clinical, socio-demographic
and other potentially relevant factors [5,6]. Cerebral blood
ﬂow (CBF), as a measure of cerebral perfusion, can be
noninvasively studied by ﬂow volume measurements in
extracranial cerebral arteries using Doppler and duplex
methods [7]. Relationship of CBF to different markers
of heart failure severity was only modestly presented in
previous papers. Therefore, we aimed to investigate the
relationship between CBF and CHF severity as well as to eval-
uate its determinants among different parameters of cardiac
dysfunction.
Methods
Study design
Based on reviewed medical history archives on the base-
line visit we screened 152 males aged 55 years and
above with CHF due to ischemic or idiopathic dilated
cardiomyopathy. Following the baseline visit 76 patients
were selected all of whom met the study inclusion cri-
teria. Inclusion criteria were as follows: duration of CHF
for longer than 1 year; echocardiographically assessed
left ventricular ejection fraction (LVEF) < 40%; etiology of
CHF: ischemic or idiopathic dilated cardiomyopathy; NYHA
functional class II and III; unchanged medication regimen
within the previous 6 weeks; clinically stable condition
with no clinical evidence of decompensate heart failure,
such as raised jugular venous pressure, ascites, hep-
atomegaly. Exclusion criteria were as follows: diabetes
mellitus determined by either self reported histories or
evidence within the hospital case notes; primary lung
disease including chronic obstructive pulmonary disease;
musculoskeletal diseases; uncontrolled hypertension of
more than 170/110mmHg; myocardial infarction or unsta-
ble angina within previous 3 months; acute or chronic
infection, inﬂammatory diseases such as sepsis, arthri-
tis or systemic connective tissue disease; symptomatic
peripheral vascular disease; alcohol abuse; serum crea-
tinine 200mmol/l; valvular cardiomyopathy or artiﬁcial
heart valve; malignant disease, signiﬁcant liver, thyroid,
suprarenal gland or pituitary disease; cardiac cachexia
deﬁned as unintentional weight loss of 7.5% body weight
over 6 months [8]. Finally, we included 71 patients because
3 patients were characterised by occlusion of internal
carotid artery, while vertebral artery was not visualised in 2
patients.The control group consisted of 20 healthy male volunteers
aged 55 years and above, who did not take medications. No
previous medical illness was reported (including diabetes or
any other cardiovascular disease).
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linical, cardiovascular and carotid color duplex
onography assessment
fter the patient gave his written consent, the medical his-
ory was reviewed, including the cause of heart failure,
omorbidities and medical history. Each patient with CHF
as categorised according to the New York Heart Associ-
tion (NYHA) criteria [9]. A physical exam was performed
o assess CHF stability. The 6-min walk test was performed
ccording to the standard protocol [10].
All patients underwent a two-dimensional Doppler
chocardiography examination (GE Vivid 7). Systolic func-
ion was quantiﬁed by measurement of LVEF using the
impson method. We also measured left ventricular
nd-diastolic diameter (LVEDD), right ventricular systolic
ressure (RVSP) and left atrial volume (LAV) according to
he ASE recommendation [11].
During an initial 20min of rest with the subjects in a
upine position, the extracranial arteries, i.e., the com-
on carotid arteries, internal carotid arteries (ICA) and the
ertebral arteries (VA) of both sides were explored with a
.0MHz linear transducer of a computed sonography system
Toshiba PowerVision 6000). The examination followed a pre-
iously described protocol [7]. CBF volume was determined
s the sum of the ﬂow volumes of the ICA and the VA of
oth sides. Resistance index, as a measure of cerebrovas-
ular resistance, was calculated as follows: (peak systolic
elocity end diastolic velocity)/peak systolic velocity [12].
ncluded subjects did not have hemodynamically signiﬁcant
tenosis of the common carotid artery, ICA and VA. The peak
ystolic velocity value averaged from both ICA and VA was
sed, as well. Intima-media thickness was measured on the
ar wall of the right and left common carotid artery, the
arotid bulb, and the ICA [13]. The carotid intima-media
hickness was deﬁned as the mean of intima-media thickness
easurements at these six sites.
Quality of life was estimated from The ‘Minnesota — Liv-
ng with Heart Failure Questionnaire’ [14]. The Tei index is
eﬁned as the sum of isovolumic contraction and relaxation
ime divided by the ejection time. This index is a sensi-
ive indicator of overall cardiac dysfunction in patients with
ild-to-moderate CHF [15].
tatistical analysis
escriptive statistics were presented as mean values with
tandard deviation or median with interquartile range for
umeric variables, or as absolute numbers with percent-
ges for categorical variables. Evaluation of normality was
erformed with Kolmogorov—Smirnov test. Student t-test
as used to calculate differences between mean values.
ann—Whitney U-test was used to determine differences
etween median values. The Pearson coefﬁcient was used
or measuring linear correlation between variables. Partial
orrelation analysis was performed to adjust for age and
ody mass index. Finally, since variables are inter-related,
ultivariate regression analysis, backward method, was per-
ormed to assess the independent variables that may explain
BF. A p value 50.05 was considered to indicate statisti-
al signiﬁcance. Statistical analysis was performed using the
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Table 1 Demographic, clinical characteristics, color
duplex sonography of neck arteries, assessment of endothe-
lial function and echocardiogaphic measurements of CHF
patients and healthy subjects.
Variable CHF patients
(n = 71)
Healthy
subjects
(n = 20)
p value
Age (years) 68± 7 67± 7 0.909
Waist/hip ratio 1.03± 0.04 1.01± 0.06 0.086
BMI (kg/m2) 28± 5 28± 3 0.496
Duration of
disease
(years)
5± 4 —
Smoking
former/
active, n (%)
16(22)/10(14) 3(15)/5(25) 0.454
Ischemic/
idiopathic
dilatated
CMP, n (%)
56(79)/15(21) —
NYHA class
II/III, n (%)
54(76)/17(24) —
MLHFQ 30± 14 —
Six-minute
walking
distance (m)
406± 84 578± 64 <0.0001
Mean blood
pressure
(mmHg)
101± 12 103± 7 0.387
ICA ﬂow
(ml/min)
505± 144 593± 118 0.014
VA ﬂow
(ml/min)
172± 68 190± 72 0.298
CBF (ml/min) 677± 170 783± 128 0.011
PSV (cm/s) 50± 10 55± 8 0.041
RI 0.65± 0.08 0.67± 0.06 0.244
CIMT (mm) 1.00± 0.12 0.92± 0.12 0.009
LAV (ml) 95± 42 46± 14 <0.0001
LVEDD (mm) 66± 9 49± 4 <0.0001
LVMi (g/m2) 159± 44 81± 12 <0.0001
LVWT (mm) 20± 4 19± 1 0.018
LVEF (%) 29± 8 65± 5 <0.0001
RVSP (mmHg) 46± 16 29± 3 <0.0001
Tei index 0.61± 0.22 0.28± 0.12 <0.0001
Data are expressed as mean± standard deviation (Mean± SD) or
median± interquartile range (Me± IQR) or as absolute number
(%).
BMI = body mass index; CMP = cardiomyopathy; hs CRP = high
sensitive C reactive protein; MLHFQ=Minnesota Living with
Heart Failure Questionnaire; NYHA=New York Heart Associ-
ation; CBF = cerebral blood ﬂow; CIMT = carotid intima-media
thickness; FMD=ﬂow mediated dilatation; ICA = internal carotid
artery; LAV = left atrial volume; LVEF = left ventricular ejection
fraction; LVMi = left ventricular mass index; LVWT= left ventric-
ular wall thickness; PSV = peak systolic velocity; RI = resistance
index; RVSP = = right ventricular systolic pressure (n = 65/10, CHF
patients/healthy controls); VA = vertebral artery.
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PSS software for Windows, version 15 (SPSS, Inc., Chicago,
L).
esults
asic characteristics of CHF patients and healthy
ubjects
he basic clinical and biohumoral parameters of studied sub-
ects are shown in Table 1. Atrial ﬁbrillation was noted in
1%, left bundle branch block in 25%, while pacemaker was
mplanted in 9% of patients with CHF. History of myocardial
nfarction was presented in 63% of patients. Angiotensincon-
erting enzyme inhibitors were presented in 80% of patients,
5% were on b-blockers, 80% of patients were on loop diuret-
cs, 55% were on spironolactone, 65% were on aspirin and
7% on statins. No differences in age, waist/hip ratio, body
ass index and lipid proﬁle were found between patients
ith CHF and healthy subjects.
olor duplex sonography of neck arteries and
chocardiogaphic measurements
olor duplex sonography of neck arteries and echocardio-
aphic measurements in studied subjects are presented
n Table 1. CBF was decreased in patients with CHF,
hile there was no difference in resistance index between
tudied groups. CBF decreased according to NYHA class
p < 0.0001), with those in NYHA class III having level of CBF
42± 104ml/min that was 25% lower than CBF in NYHA class
I patients (719± 166ml/min). Carotid intima-media thick-
ess was signiﬁcantly greater in patients with CHF compared
o healthy controls. Echocardiographic variables of systolic
nd diastolic function were impaired in patients with CHF.
BF in patients with CHF was positively correlated with
ecreased LVEF (Fig. 1).
ig. 1 Scatter plots of the association between CBF and
VEF in elderly patients with CHF. CBF = cerebral blood ﬂow;
VEF = left ventricular ejection fraction.
Cerebral blood ﬂow in the chronic heart failure patients
Table 2 Multivariate regression analysis (backward model)
with cerebral blood ﬂow as dependent variable in elderly
CHF males.
Variable B p value F (p)
CBF (Constant) 0.454 5.121
MLHFQ −0.003 0.049 (0.001)
LVEF 0.006 0.031
FMD 0.184 0.099
Tei index 0.220 0.021
r2 = 0.289
B = parameter estimate; F = Fisher test. CBF = cerebral blood
ﬂow; FMD= low mediated dilatation; LVEF = left ventricular ejec-
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etion fraction; MLHFQ=Minnesota Living with Heart Failure
Questionnaire.
Multivariate regression analysis
Multivariate regression analysis with backward model was
used to asses the independent variables that may affect CBF
(Table 2). The independent variables entered in the model
were: age, body mass index, mean blood pressure, quality
of life score, 6-min walk distance, LVEF and Tei index. LVEF
was independently associated with reduced CBF in patients
with CHF.
Discussion
The objective of this study was to investigate the asso-
ciation of CBF with different parameters of heart failure
severity in elderly males. The major observations in this
study are that: (1) elderly men with CHF demonstrated
reduced CBF compared to healthy controls; (2) reduced CBF
was also associated with deteriorated physical performance
capacity (6-min walk distance), impaired quality of life,
and pulmonary hypertension; (4) clinically more advanced
CHF, expressed as NYHA class, was related to greater reduc-
tion of CBF. In this study, CBF was signiﬁcantly reduced
by 14% in elderly patients with CHF compared to healthy
controls. Similarly, Choi et al. [16] have shown that global
CBF (measured by radionuclide angiography) was decreased
by approximately 19% in patients with CHF compared with
normal controls. Patients with heart failure showed dam-
age to multiple brain regions that play signiﬁcant roles in
autonomic nervous system control and cognitive function
including mood regulation, memory processing, pain and
language [3]. One of the major factors that may lead to cog-
nitive impairment is cerebral hypoperfusion demonstrated
in our as well as in previous studies [17]. CBF is regulated by
perfusion pressure and vascular resistance. The autoregula-
tion of blood ﬂow over a wide range of perfusion pressures
is one of the characteristics of brain circulation. Com-
pensatory mechanisms maintain perfusion to vital organs,
such as brain in response to the progressive reduction of
cardiac output. One of the chronic adaptations of the circu-
latory system is peripheral vasoconstriction which may be
provoked by the heart failure-induced activation of neu-
rohormonal systems [18]. In agreement with our results,
cerebral vascular resistance, expressed by resistance index,
was not elevated in patients with mild-to-moderate CHF
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ompared to healthy controls [19]. Therefore, decreased
erfusion pressure as a consequence of reduced systolic left
entricular function in patients with CHF may be marked
s principal factor of reduced CBF. Low LVEF was the inde-
endent determinant of impaired CBF in our patients with
HF. Thus, it can be speculated that cerebral hypoperfusion
ue to left ventricular systolic dysfunction may contribute
o brain injury secondary to low cardiac output. A correla-
ion between cardiac index and intracranial hemodynamics
as been reported [20]. However, Eicke et al. [21] showed
o correlation between LVEF and CBF supporting the con-
ept that CBF is independent of cardiac output. In addition,
hoi et al. [16] showed that CBF was not correlated to LVEF
n patients with CHF, suggesting that the LVEF was not a
actor determining the degree of breakdown of the autoreg-
lation of CBF. This discrepancy may be explained that in the
atients with more severe CHF such as those in the study
f Choi et al., factors other than LVEF contributed more to
BF, such as NYHA functional class and neurohormonal acti-
ation. Our recent published data presents relation between
BF reduction and neurohormonal activation in CHF patients
22].
The same study reported an inverse association between
BF with RVSP which is in agreement with our ﬁnding.
inally, reduced CBF in our study was signiﬁcantly associated
ith impaired physical performance; measured by 6-min
alk test contrary to previous data [19]. The 6-min walk
est is a safe and simple clinical tool that strongly and inde-
endently predicts morbidity and mortality in patients with
HF [23].
Color duplex volumetric test of the brain-feeding arteries
an only yield information about the relative contributions
f the anterior and posterior cerebral circulation to global
BF volume. We found a contribution of the VA to global
BF volume of 25% which remained almost constant with
ncreasing age. Previously, it was estimated that the VA con-
ribute 24% of the global CBF volume in healthy subjects
24]. To date, there are no reports on the relative contri-
utions of the anterior and posterior circulation to global
BF volume in patients with CHF. Carotid intima-media
hickness was greater in our patients with CHF compared
o healthy controls. High carotid intima-media thickness
as marked as an independent risk factor for incidence
f heart failure requiring hospitalisation [25]. Increased
arotid intima-media thickness was shown to be a power-
ul predictor of coronary and cerebrovascular events, as
ell [26]. Although both parameters were impaired in our
atients, the lack of a link between them suggests that they
ay represent independent surrogates that measure differ-
nt pathophysiological aspect of heart failure progression.
The limitation of our study is a relatively small number
f studied patients. Our cohort comprised a highly selected
HF sample and is thus less representative of the overall
HF population. The relations between CBF and different
ariables were examined in a cross-sectional study, which
annot prove a causal relation between these variables.
olor duplex volumetric examination of the brain feeding
xtracranial arteries is a highly reproducible and noninvasive
echnique. The reliability of the method should be con-
rmed in comparative studies with established radionuclide
rocedures which is difﬁcult for ethical reasons. How-
ver, reduction of CBF in our patients with CHF compared
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o healthy controls was similar to the value obtained by
adionuclide technique. In this study, we did not perform
valuation of mental status or brain imaging. Therefore, we
annot say that reduced CBF was associated with neuropsy-
hiatric or brain morphologic disorders among patients with
HF. Finally, it would be of interest to evaluate the impact of
iminished CBF on major clinical outcomes in future studies.
In conclusion, we have shown that CBF was reduced in
lderly males with mild to moderate CHF, and was indepen-
ently associated with factors that represent the severity
f CHF. Reduced CBF was associated with impaired physi-
al performance, and deteriorated quality of life, as well.
uture studies are now needed to tease out possible asso-
iation of CBF with cerebral disorders known to be more
otentiated in the population with heart failure as well as
o investigate the possible underlying mechanisms.
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